View Item 

Show simple item record

Cytokine gene polymorphisms in chronic hepatitis B: a step up the immunology ladder

dc.contributor.authorWai, Chun-Taoen_US
dc.contributor.authorFontana, Robert Johnen_US
dc.date.accessioned2010-06-01T18:52:33Z
dc.date.available2010-06-01T18:52:33Z
dc.date.issued2003-01en_US
dc.identifier.citationWai, Chun T . ; Fontana, Robert J . (2003). "Cytokine gene polymorphisms in chronic hepatitis B: a step up the immunology ladder." The American Journal of Gastroenterology 98(1): 6-8. <http://hdl.handle.net/2027.42/72069>en_US
dc.identifier.issn0002-9270en_US
dc.identifier.issn1572-0241en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/72069
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=12526929&dopt=citationen_US
dc.format.extent39426 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights2003 by Am. Coll. of Gastroenterologyen_US
dc.titleCytokine gene polymorphisms in chronic hepatitis B: a step up the immunology ladderen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDivision of Gastroenterology University of Michigan Medical School Ann Arbor, Michigan USAen_US
dc.identifier.pmid12526929en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/72069/1/j.1572-0241.2003.07169.x.pdf
dc.identifier.doi10.1111/j.1572-0241.2003.07169.xen_US
dc.identifier.sourceThe American Journal of Gastroenterologyen_US
dc.identifier.citedreferenceMast E.E., Alter M.J., Margolis H.S.. Strategies to prevent and control hepatitis B and C virus infections: A global perspective. Vaccine 1999; 17: 1730 – 1733.en_US
dc.identifier.citedreferenceMargolis H.S., Alter M.J., Hadler S.C.. Hepatitis B: Evolving epidemiology and implications for control. Semin Liv Dis 1991; 11: 84 – 92.en_US
dc.identifier.citedreferenceTassopoulos N.C., Papaevangelou G.J., Sjogren M.H., et al. Natural history of acute hepatitis B surface antigen hepatitis in Greek adults. Gastroenterology 1987; 92: 1844 – 1850.en_US
dc.identifier.citedreferenceMayerat C., Mantegani A., Frei P.C.. Does hepatitis B virus genotype influence the clinical outcome of HBV infection?. J Viral Hepatitis 1999; 6: 299 – 304.en_US
dc.identifier.citedreferenceWebster G.J., Reignat S., Maini M.K., et al. Incubation phase of acute hepatitis B in man: Dynamic of cellular immune mechanisms. Hepatology 2000; 32: 1117 – 1124.en_US
dc.identifier.citedreferenceChisari F.V.. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995; 13: 29 – 60.en_US
dc.identifier.citedreferenceRehermann B., Ferrari C., Pasquinelli C., Chisari F.V.. The hepatitis B virus persists for decades after patients, recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med 1996; 2: 1104 – 1108.en_US
dc.identifier.citedreferenceGuidotti L.G., Chisari F.V.. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 2001; 19: 65 – 91.en_US
dc.identifier.citedreferenceLohr H., Gerken G., Schlicht H., et al. Low frequency of cytotoxic liver-infiltrating T lymphocytes specific for endogenous processed surface and core proteins in chronic hepatitis B. J Infect Dis 1993; 168: 1133 – 1139.en_US
dc.identifier.citedreferenceBertoletti A., D’Elios M.M., Boni C., et al. Different cytokine profiles of intrahepatic T cells in chronic hepatitis B and hepatitis C virus infections. Gastroenterology 1997; 112: 193 – 199.en_US
dc.identifier.citedreferenceLivingston B.D., Alexander J., Crimi C., et al. Altered helper T lymphocyte function associated with chronic hepatitis B virus infection and its role in response to therapeutic vaccination in humans. J Immunol 1999; 162: 3088 – 3095.en_US
dc.identifier.citedreferenceThursz M.R., Kwiatkowski D., Alsopp C.E.M., et al. Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N Engl J Med 1995; 332: 1065 – 1069.en_US
dc.identifier.citedreferenceThursz M.. MHC and the viral hepatitides. Quart J Med 2001; 94: 287 – 291.en_US
dc.identifier.citedreferenceBen Ari Z, Mor E, Kfir B, et al. Cytokine gene polymorphisms in patients infected with hepatitis B virus. Am J Gastroenterol 2003; 98: 144 – 150.en_US
dc.identifier.citedreferenceBidwell J.L., Wood N.A., Morse H.R., et al. Human cytokine gene nucleotide sequence alignments. Eur J Immunogenet 1998; 25: 83 – 265.en_US
dc.identifier.citedreferenceGewaltig J., Mangasser-Stephan K., Gartung C., et al. Association of polymorphisms of the transforming growth factor-B1 gene with the rate of progression of HCV induced liver fibrosis. Clin Chim Acta 2002; 316: 83 – 94.en_US
dc.identifier.citedreferencePowell E.E., Edwards-Smith C.J., Hay J.L., et al. Host genetic factors influence disease progression in chronic hepatitis C. Hepatology 2000; 31: 828 – 833.en_US
dc.identifier.citedreferenceKohler T., Kruger A., Gerken G., et al. A tumor necrosis factor-alpha (TNFa) promoter polymorphism is associated with chronic hepatitis B. Clin Exp Immunol 1998; 111: 579 – 582.en_US
dc.identifier.citedreferencePravica V., Asderakis A., Perrey C., et al. In vitro production of IFN-Γ correlates with CA repeat polymorphism in the human IFN-Γ gene. Eur J Immunogenet 1999; 26: 1 – 3.en_US
dc.identifier.citedreferenceDiBisceglie A.M., Rustgi V.K., Kassianides C., et al. Therapy of chronic hepatitis B with recombinant human alpha and gamma interferon. Hepatology 1990; 11: 266 – 270.en_US
dc.identifier.citedreferenceBoni C., Bertoletti A., Penna A., et al. Lamivudine treatment can restore T-cell responsiveness in chronic hepatitis B. Br J Clin Invest 1998; 102: 968 – 975.en_US
dc.identifier.citedreferenceBoni C., Penna A., Ogg G.S., et al. Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: New perspectives for immune therapy. Hepatology 2001; 33: 963 – 971.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1572-0241.2003.07169.x.pdf
Size:
38.50KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.